Evelo Biosciences shares are trading higher after the company wins U.S. Patent for prebiotic compositions and methods of use thereof for modulation of the microbiome.
Portfolio Pulse from Benzinga Newsdesk
Evelo Biosciences has been granted a U.S. Patent for prebiotic compositions and methods of use for modulation of the microbiome, causing its shares to trade higher.
June 16, 2023 | 9:24 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Evelo Biosciences' stock price is trading higher after winning a U.S. Patent for prebiotic compositions and methods of use for microbiome modulation.
The granting of a U.S. Patent for Evelo Biosciences' prebiotic compositions and methods of use is a significant milestone for the company. This achievement validates the company's research and development efforts and may lead to increased investor confidence, resulting in a higher stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100